| Ambetter Health Texas Superior Marketplace Clinical | Teplizumab-mzwv | 2025-12-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Step Therapy | 2025-12-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Teplizumab-mzwv | 2025-12-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Tiopronin Delayed-Release | 2025-12-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Valbenazine | 2025-12-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Tiopronin Delayed-Release | 2025-12-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Valbenazine | 2025-12-01 |
| UHC Commercial Medical & Drug | Benlysta® (Belimumab) – Commercial Medical Benefit Drug Policy | 2025-12-01 |
| UHC Commercial Medical & Drug | Evenity® (Romosozumab-Aqqg) – Commercial Medical Benefit Drug Policy | 2025-12-01 |
| UHC Commercial Medical & Drug | Ophthalmologic Complement Inhibitors – Commercial Medical Benefit Drug Policy | 2025-12-01 |